Bio-Rad Laboratories Inc (NYSE:BIO)
$ 330.53 2.17 (0.66%) Market Cap: 9.23 Bil Enterprise Value: 9.00 Bil PE Ratio: 0 PB Ratio: 1.24 GF Score: 78/100

Q3 2024 Bio Rad Laboratories Inc Earnings Call Transcript

Oct 30, 2024 / 09:00PM GMT
Release Date Price: $330.58 (-0.32%)
Operator

Hello, everyone and welcome to today's Bio-Rad third-quarter 2024 results conference call and webcast. (Operator Instructions) Please note today's session is being recorded. (Operator Instructions)

It is now my pleasure to turn the floor over to Head of Investor Relations, Edward Chung. Welcome, sir.

Edward Chung
Bio Rad Laboratories Inc - Vice President - Investor Relations

Good afternoon, everyone. And thank you for joining us today. We will review the third-quarter 2024 financial results and provide an update on key business trends for Bio-Rad. With me on the call today are Norman Schwartz, our Chief Executive Officer; Jon DiVincenzo, President and Chief Operating Officer, and Roop Lakkaraju, Executive Vice President and Chief Financial Officer.

Before we begin our review, I'd like to remind everyone that we'll be making forward-looking statements about management's goals, plans, and expectations, our future financial performance, and other matters. These statements are based on assumptions and expectations of future events that are

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot